Loading
PDBj
メニューPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

2NC9

Apo solution structure of Hop TPR2A

2NC9 の概要
エントリーDOI10.2210/pdb2nc9/pdb
NMR情報BMRB: 26011
分子名称Stress-induced-phosphoprotein 1 (1 entity in total)
機能のキーワードchaperone, heat-shock, hsp90, tpr
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計15569.57
構造登録者
Darby, J.F.,Vidler, L.R.,Simpson, P.J.,Matthews, S.J.,Sharp, S.Y.,Pearl, L.H.,Hoelder, S.,Workman, P. (登録日: 2016-03-23, 公開日: 2017-03-29, 最終更新日: 2024-05-01)
主引用文献Darby, J.F.,Vidler, L.R.,Simpson, P.J.,Al-Lazikani, B.,Matthews, S.J.,Sharp, S.Y.,Pearl, L.H.,Hoelder, S.,Workman, P.
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approaches.
Sci Rep, 10:16000-16000, 2020
Cited by
PubMed Abstract: Heat shock protein 90 (Hsp90) is a molecular chaperone that plays an important role in tumour biology by promoting the stabilisation and activity of oncogenic 'client' proteins. Inhibition of Hsp90 by small-molecule drugs, acting via its ATP hydrolysis site, has shown promise as a molecularly targeted cancer therapy. Owing to the importance of Hop and other tetratricopeptide repeat (TPR)-containing cochaperones in regulating Hsp90 activity, the Hsp90-TPR domain interface is an alternative site for inhibitors, which could result in effects distinct from ATP site binders. The TPR binding site of Hsp90 cochaperones includes a shallow, positively charged groove that poses a significant challenge for druggability. Herein, we report the apo, solution-state structure of Hop TPR2A which enables this target for NMR-based screening approaches. We have designed prototype TPR ligands that mimic key native 'carboxylate clamp' interactions between Hsp90 and its TPR cochaperones and show that they block binding between Hop TPR2A and the Hsp90 C-terminal MEEVD peptide. We confirm direct TPR-binding of these ligands by mapping H-N HSQC chemical shift perturbations to our new NMR structure. Our work provides a novel structure, a thorough assessment of druggability and robust screening approaches that may offer a potential route, albeit difficult, to address the chemically challenging nature of the Hop TPR2A target, with relevance to other TPR domain interactors.
PubMed: 32994435
DOI: 10.1038/s41598-020-71969-w
主引用文献が同じPDBエントリー
実験手法
SOLUTION NMR
構造検証レポート
Validation report summary of 2nc9
検証レポート(詳細版)ダウンロードをダウンロード

227111

件を2024-11-06に公開中

PDB statisticsPDBj update infoContact PDBjnumon